⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
prnewswire.com
MRK
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
businesswire.com
MRK
Ability Biotherapeutics nomme Angèle Maki, Ph. D., au poste de cheffe de la direction commerciale
businesswire.com
BMY
GENK
MRK
LLY
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
globenewswire.com
MRK
Senior Pharma and Biotech Leaders to Convene for Industry Forum at San Francisco CEO Ahead of JP Morgan Healthcare Conference
accessnewswire.com
JPM
JNJ
AMGN
MRK
BMY
REGN
Strategic Pharma Collaborations Propel RCC Market Growth
globenewswire.com
MRK
AZN
PFE
EXEL
BioNxt treibt „Melt in Your Mouth“-Cladribin-Formulierung voran, um die Behandlung von MS-Patienten mit Dysphagie zu verbessern
accessnewswire.com
MRK
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AMGN
PFE
LLY
AZN
BMY
NVS
SNY
GSK
UCB
ARQT
REGN
INCY
ABBV
BIIB
MRK
JNJ
VNDA
RAPT
CHAI
ONON
ION
ASMB
CRVS
APG
KSCP
KYMR
XBI
IBB
ADSK
CDNS
SNPS
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
newsfilecorp.com
MRK
Merck Sharp & Dohme LLC Data Breach Under Investigation by Levi & Korsinsky, LLP
accessnewswire.com
MRK